Lean body mass

OTHER2 trials

Sponsors

Radboud University Medical Center, Universitair Medisch Centrum Utrecht

Conditions

Breast CancerMetastatic Castration-resistant Prostate Carcinomaadenocarcinoma colon cancer

Unknown Phase

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

CompletedNCT01621425

Radboud University Medical CenterBreast Cancer, Metastatic Castration-resistant Prostate Carcinoma

Start: 2012-06-30End: 2015-05-31Updated: 2015-08-13

The PLCRC-PROTECT+ study: PLCRC cohort: lean body mass and treatment toxicities in adjuvant chemotherapy-receiving colon cancer patients

Active, not recruitingNL-OMON47422

Universitair Medisch Centrum Utrechtadenocarcinoma colon cancer

Start: 2017-01-27Target: 150Updated: 2024-02-28